Cell and Gene Therapy CDMO Market
Cell and Gene Therapy CDMO Market
Based on market forecasts, the cell and gene therapy CDMO sector will expand from USD 6.41 billion in 2024 to USD 75.32 billion by 2034, experiencing a CAGR of 27.94%. In 2024, North America led the cell and gene therapy CDMO market with a 41% share, while Asia Pacific is set for the fastest growth. Oncology dominated by indication, but rare diseases are gaining momentum. Pre-clinical led by phase, with clinical growing rapidly. Cell therapy was dominant, while gene-modified cell therapy is surging.
Report ID: 10001
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 6.41 Bn
Forecast Year,
USD USD 75.32 Bn
CAGR, 2025 -
27.94%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Cell and Gene Therapy CDMO Market Size Analysis
Cell and Gene Therapy CDMO Market Size By Type of Therapy_USD 2024 to 2034 (USD )
| Type of Therapy_USD | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene Therapy | 1.58 | 2.01 | 2.57 | 3.27 | 4.17 | 5.32 | 6.79 | 8.66 | 11.04 | 14.08 | 17.96 |
| Cell Therapy | 1.26 | 1.62 | 2.09 | 2.69 | 3.46 | 4.44 | 5.72 | 7.35 | 9.46 | 12.16 | 15.65 |
| Stem Cell Therapy | 1.14 | 1.46 | 1.87 | 2.39 | 3.07 | 3.93 | 5.04 | 6.46 | 8.29 | 10.62 | 13.62 |
| CAR-T Therapy | 1.39 | 1.77 | 2.26 | 2.89 | 3.69 | 4.71 | 6.01 | 7.67 | 9.79 | 12.49 | 15.95 |
| Other Cell Therapies | 0.95 | 1.21 | 1.54 | 1.97 | 2.51 | 3.21 | 4.09 | 5.23 | 6.67 | 8.51 | 10.86 |
Cell and Gene Therapy CDMO Market Size By Type of Therapy_Share 2024 to 2034 (USD )
| Type of Therapy_Share | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene Therapy | 25.00 | 24.93 | 24.85 | 24.78 | 24.70 | 24.63 | 24.55 | 24.48 | 24.40 | 24.33 | 24.25 |
| Cell Therapy | 20.00 | 20.11 | 20.22 | 20.34 | 20.45 | 20.56 | 20.68 | 20.79 | 20.90 | 21.02 | 21.13 |
| Stem Cell Therapy | 18.00 | 18.04 | 18.08 | 18.12 | 18.16 | 18.20 | 18.24 | 18.28 | 18.32 | 18.35 | 18.39 |
| CAR-T Therapy | 22.00 | 21.95 | 21.91 | 21.86 | 21.82 | 21.77 | 21.73 | 21.68 | 21.64 | 21.59 | 21.54 |
| Other Cell Therapies | 15.00 | 14.97 | 14.94 | 14.90 | 14.87 | 14.84 | 14.81 | 14.77 | 14.74 | 14.71 | 14.68 |
Cell and Gene Therapy CDMO Market Size By Type of Manufacturing Se_USD 2024 to 2034 (USD )
| Type of Manufacturing Se_USD | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Development Services | 1.89 | 2.42 | 3.09 | 3.94 | 5.03 | 6.41 | 8.19 | 10.45 | 13.33 | 17.02 | 21.72 |
| Manufacturing Services | 3.47 | 4.45 | 5.71 | 7.31 | 9.37 | 12.01 | 15.40 | 19.74 | 25.30 | 32.44 | 41.58 |
| Other Services | 0.95 | 1.21 | 1.54 | 1.96 | 2.50 | 3.19 | 4.06 | 5.18 | 6.60 | 8.42 | 10.73 |
Cell and Gene Therapy CDMO Market Size By Type of Manufacturing _Share 2024 to 2034 (USD )
| Type of Manufacturing _Share | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Development Services | 30.00 | 29.93 | 29.87 | 29.80 | 29.74 | 29.67 | 29.60 | 29.54 | 29.47 | 29.41 | 29.34 |
| Manufacturing Services | 55.00 | 55.12 | 55.23 | 55.35 | 55.47 | 55.58 | 55.70 | 55.82 | 55.93 | 56.05 | 56.16 |
| Other Services | 15.00 | 14.95 | 14.90 | 14.85 | 14.80 | 14.75 | 14.70 | 14.65 | 14.59 | 14.54 | 14.49 |
Cell and Gene Therapy CDMO Market Size By Cell and Gene Therapy Mo_USD 2024 to 2034 (USD )
| Cell and Gene Therapy Mo_USD | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Viral Vectors | 2.52 | 3.23 | 4.14 | 5.30 | 6.78 | 8.68 | 11.11 | 14.23 | 18.22 | 23.32 | 29.86 |
| Non-Viral Vectors | 1.89 | 2.42 | 3.10 | 3.97 | 5.08 | 6.49 | 8.31 | 10.64 | 13.61 | 17.41 | 22.28 |
| CRISPR/Cas9 and Other Gene Editing Tools | 1.89 | 2.42 | 3.09 | 3.95 | 5.04 | 6.44 | 8.22 | 10.50 | 13.42 | 17.14 | 21.89 |
Cell and Gene Therapy CDMO Market Size By Cell and Gene Therapy _Share 2024 to 2034 (USD )
| Cell and Gene Therapy _Share | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Viral Vectors | 40.00 | 40.03 | 40.07 | 40.10 | 40.13 | 40.17 | 40.20 | 40.23 | 40.26 | 40.30 | 40.33 |
| Non-Viral Vectors | 30.00 | 30.01 | 30.02 | 30.03 | 30.04 | 30.05 | 30.06 | 30.07 | 30.08 | 30.09 | 30.10 |
| CRISPR/Cas9 and Other Gene Editing Tools | 30.00 | 29.96 | 29.91 | 29.87 | 29.83 | 29.79 | 29.74 | 29.70 | 29.66 | 29.61 | 29.57 |
Cell and Gene Therapy CDMO Market Size By Therapeutic Area_USD 2024 to 2034 (USD )
| Therapeutic Area_USD | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 2.84 | 3.63 | 4.66 | 5.96 | 7.63 | 9.77 | 12.51 | 16.01 | 20.50 | 26.24 | 33.59 |
| Neurology | 1.26 | 1.62 | 2.07 | 2.65 | 3.40 | 4.35 | 5.58 | 7.14 | 9.15 | 11.72 | 15.01 |
| Cardiovascular | 0.76 | 0.97 | 1.25 | 1.60 | 2.05 | 2.63 | 3.37 | 4.32 | 5.54 | 7.11 | 9.12 |
| Metabolic Disorders | 0.63 | 0.80 | 1.03 | 1.31 | 1.67 | 2.13 | 2.72 | 3.47 | 4.43 | 5.66 | 7.22 |
| Other Therapeutic Areas | 0.82 | 1.04 | 1.33 | 1.69 | 2.15 | 2.73 | 3.48 | 4.42 | 5.62 | 7.15 | 9.10 |
Cell and Gene Therapy CDMO Market Size By Therapeutic Area_Share 2024 to 2034 (USD )
| Therapeutic Area_Share | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 45.00 | 45.04 | 45.08 | 45.12 | 45.15 | 45.19 | 45.23 | 45.27 | 45.30 | 45.34 | 45.38 |
| Neurology | 20.00 | 20.03 | 20.06 | 20.08 | 20.11 | 20.14 | 20.16 | 20.19 | 20.22 | 20.25 | 20.27 |
| Cardiovascular | 12.00 | 12.03 | 12.06 | 12.09 | 12.13 | 12.16 | 12.19 | 12.22 | 12.25 | 12.28 | 12.31 |
| Metabolic Disorders | 10.00 | 9.97 | 9.95 | 9.92 | 9.90 | 9.87 | 9.85 | 9.82 | 9.80 | 9.77 | 9.75 |
| Other Therapeutic Areas | 13.00 | 12.93 | 12.86 | 12.78 | 12.71 | 12.64 | 12.57 | 12.50 | 12.43 | 12.36 | 12.29 |
Cell and Gene Therapy CDMO Market Size By End-User_USD 2024 to 2034 (USD )
| End-User_USD | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biopharmaceutical Companies | 3.79 | 4.84 | 6.20 | 7.94 | 10.16 | 13.00 | 16.64 | 21.29 | 27.24 | 34.87 | 44.62 |
| Academic and Research Institutions | 1.26 | 1.61 | 2.06 | 2.63 | 3.35 | 4.28 | 5.46 | 6.97 | 8.90 | 11.36 | 14.50 |
| Contract Development & Manufacturing Organizations (CDMOs) | 1.26 | 1.62 | 2.07 | 2.65 | 3.39 | 4.34 | 5.55 | 7.11 | 9.10 | 11.64 | 14.90 |
Cell and Gene Therapy CDMO Market Size By End-User_Share 2024 to 2034 (USD )
| End-User_Share | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biopharmaceutical Companies | 60.00 | 60.03 | 60.06 | 60.08 | 60.11 | 60.14 | 60.17 | 60.19 | 60.22 | 60.25 | 60.28 |
| Academic and Research Institutions | 20.00 | 19.96 | 19.92 | 19.88 | 19.84 | 19.80 | 19.75 | 19.71 | 19.67 | 19.63 | 19.59 |
| Contract Development & Manufacturing Organizations (CDMOs) | 20.00 | 20.01 | 20.03 | 20.04 | 20.05 | 20.07 | 20.08 | 20.09 | 20.11 | 20.12 | 20.13 |
Cell and Gene Therapy CDMO Market Size By Geography_USD 2024 to 2034 (USD )
| Geography_USD | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.40 | 3.07 | 3.93 | 5.02 | 6.43 | 8.22 | 10.52 | 13.45 | 17.21 | 22.02 | 28.17 |
| Europe | 1.58 | 2.02 | 2.59 | 3.31 | 4.24 | 5.43 | 6.95 | 8.90 | 11.39 | 14.58 | 18.67 |
| Asia Pacific | 1.39 | 1.78 | 2.27 | 2.91 | 3.72 | 4.76 | 6.09 | 7.79 | 9.96 | 12.74 | 16.30 |
| Latin America | 0.63 | 0.81 | 1.03 | 1.32 | 1.70 | 2.17 | 2.78 | 3.56 | 4.56 | 5.84 | 7.47 |
| Middle East and Africa | 0.32 | 0.40 | 0.51 | 0.64 | 0.82 | 1.04 | 1.32 | 1.67 | 2.12 | 2.69 | 3.42 |
Cell and Gene Therapy CDMO Market Size By Geography_Share 2024 to 2034 (USD )
| Geography_Share | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 38.00 | 38.01 | 38.01 | 38.02 | 38.02 | 38.03 | 38.03 | 38.04 | 38.04 | 38.05 | 38.05 |
| Europe | 25.00 | 25.02 | 25.04 | 25.07 | 25.09 | 25.11 | 25.13 | 25.16 | 25.18 | 25.20 | 25.22 |
| Asia Pacific | 22.00 | 22.00 | 22.00 | 22.01 | 22.01 | 22.01 | 22.01 | 22.02 | 22.02 | 22.02 | 22.02 |
| Latin America | 10.00 | 10.01 | 10.02 | 10.03 | 10.04 | 10.05 | 10.06 | 10.07 | 10.07 | 10.08 | 10.09 |
| Middle East and Africa | 5.00 | 4.96 | 4.92 | 4.88 | 4.84 | 4.80 | 4.76 | 4.73 | 4.69 | 4.65 | 4.61 |
Cell and Gene Therapy CDMO Market 2025-2035
Cell and Gene Therapy CDMO Market 2025-2035
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
